Valerii I Bukhtiyarov
Overview
Explore the profile of Valerii I Bukhtiyarov including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
32
Citations
272
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Chowdhury M, Oladun C, Ariyasingha N, Samoilenko A, Bawardi T, Burueva D, et al.
Analyst
. 2024 Nov;
149(24):5832-5842.
PMID: 39530397
Proton-hyperpolarized contrast agents are attractive because they can be imaged on virtually any clinical MRI scanner, which is typically equipped to scan only protons rather than heteronuclei (, anything besides...
2.
Ariyasingha N, Samoilenko A, Chowdhury M, Nantogma S, Oladun C, Birchall J, et al.
Chem Biomed Imaging
. 2024 Nov;
2(10):698-710.
PMID: 39483636
NMR hyperpolarization dramatically improves the detection sensitivity of magnetic resonance through the increase in nuclear spin polarization. Because of the sensitivity increase by several orders of magnitude, additional applications have...
3.
Ariyasingha N, Chowdhury M, Samoilenko A, Salnikov O, Chukanov N, Kovtunova L, et al.
Chemistry
. 2024 Feb;
30(25):e202304071.
PMID: 38381807
Hyperpolarized Xe gas was FDA-approved as an inhalable contrast agent for magnetic resonance imaging of a wide range of pulmonary diseases in December 2022. Despite the remarkable success in clinical...
4.
Fedorov A, Bukhtiyarov A, Panafidin M, Prosvirin I, Zubavichus Y, Bukhtiyarov V
Nanomaterials (Basel)
. 2024 Jan;
14(1).
PMID: 38202512
Bimetallic nanoparticles expand the possibilities of catalyst design, providing an extra degree of freedom for tailoring the catalyst structure in comparison to purely monometallic systems. The distribution mode of two...
5.
Nartova A, Kvon R, Kovtunova L, Skovpin I, Koptyug I, Bukhtiyarov V
Int J Mol Sci
. 2023 Nov;
24(21).
PMID: 37958626
Immobilized [Ir(COD)Cl]-Linker/TiO catalysts with linkers containing Py, P(Ph) and N(CH) functional groups were prepared. The catalysts were tested via propene hydrogenation with parahydrogen in a temperature range from 40 °C...
6.
Ariyasingha N, Samoilenko A, Birchall J, Chowdhury M, Salnikov O, Kovtunova L, et al.
ACS Sens
. 2023 Sep;
8(10):3845-3854.
PMID: 37772716
Hyperpolarized magnetic resonance imaging (MRI) contrast agents are revolutionizing the field of biomedical imaging. Hyperpolarized Xe-129 was recently FDA approved as an inhalable MRI contrast agent for functional lung imaging...
7.
Salnikov O, Burueva D, Kovtunova L, Bukhtiyarov V, Kovtunov K, Koptyug I
Chemphyschem
. 2022 Jan;
23(7):e202200072.
PMID: 35099100
In this work the mechanism of methylenecyclobutane hydrogenation over titania-supported Rh, Pt and Pd catalysts was investigated using parahydrogen-induced polarization (PHIP) technique. It was found that methylenecyclobutane hydrogenation leads to...
8.
Anand M, Beale A, Boronat M, Bowker M, Bugaev A, Bukhtiyarov V, et al.
Faraday Discuss
. 2021 May;
229:378-421.
PMID: 34008684
No abstract available.
9.
Salnikov O, Chukanov N, Kovtunova L, Bukhtiyarov V, Kovtunov K, Shchepin R, et al.
Chemphyschem
. 2021 Apr;
22(13):1389-1396.
PMID: 33929077
Magnetic resonance imaging of [1- C]hyperpolarized carboxylates (most notably, [1- C]pyruvate) allows one to visualize abnormal metabolism in tumors and other pathologies. Herein, we investigate the efficiency of H and...
10.
Chekmenev E, Goodson B, Bukhtiyarov V, Koptyug I
Chemphyschem
. 2021 Apr;
22(8):710-715.
PMID: 33825286
Demonstration of parahydrogen-induced polarization effects in hydrogenations catalyzed by heterogeneous catalysts instead of metal complexes in a homogeneous solution has opened an entirely new dimension for parahydrogen-based research, demonstrating its...